Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6629 record(s)

Req # A-2024-000447

Adverse Drug Reactions (ADRs). Report numbers: E2B_07160708, E2B_07185457.

Organization: Health Canada

288 page(s)
October 2024

Req # A-2024-000451

Adverse Drug Reactions (ADRs). Report numbers: E2B_05276196, E2B_05276215, E2B_05302893, E2B_00325877, E2B_00767615.

Organization: Health Canada

133 page(s)
October 2024

Req # A-2024-000483

Adverse Drug Reactions (ADRs). Report numbers: 001093304, 001087032, E2B_07127082.

Organization: Health Canada

131 page(s)
October 2024

Req # A-2024-000485

Adverse Drug Reactions (ADRs) for GAMMAGARD S/D. Report numbers: 001088321, 001088325, 001095973, 001088327, 001088116, 001088328, 001088316. ADRs for Mesalamine. Report numbers: E2B_07174694, E2B_07183816, E2B_07174424.

Organization: Health Canada

80 page(s)
October 2024

Req # A-2024-000495

Adverse Drug Reactions (ADRs). Report numbers: 000982835, 000997954, 001001046, E2B_02247251, E2B_03419120.

Organization: Health Canada

109 page(s)
October 2024

Req # A-2024-000507

Adverse Drug Reactions (ADRs). Report numbers: E2B_02585464, E2B_02840835, E2B_03467903, E2B_03470780, E2B_05300669.

Organization: Health Canada

675 page(s)
October 2024

Req # A-2024-000508

Adverse Drug Reactions (ADRs). Report numbers: E2B_06801078, 1067313, 1068172, 1074680, 1081820, E2B_06942490, E2B_06942592.

Organization: Health Canada

49 page(s)
October 2024

Req # A-2024-000511

Adverse Drug Reactions (ADRs). Report numbers: E2B_05783579, E2B_06121233, E2B_06147088, E2B_06188891, E2B_06190588.

Organization: Health Canada

682 page(s)
October 2024

Req # A-2024-000523

Adverse Drug Reactions (ADRs). Report numbers: 001087795, E2B_07183866, 001088332, E2B_07175059, E2B_07169412, E2B_07184552, E2B_07184167, E2B_07184617, 001089696, E2B_07184629.

Organization: Health Canada

100 page(s)
October 2024

Req # A-2024-000555

Adverse Drug Reactions (ADRs). Report numbers: 001091778, E2B_07213153, E2B_07213161, E2B_07215510, E2B_07236003, E2B_07238161.

Organization: Health Canada

72 page(s)
October 2024
Date modified: